[Prognostic value of gliofibrillary protein assay in malignant gliomas treated with chemo- and radiotherapy].
The value of GFA determination for predicting the survival of patients after surgical treatment of a malignant brain tumor was studied. GFA was measured on a histologically controlled fragment of the tumor. No significant correlation was found between the level of GFA and the survival time of patients treated by chemotherapy and radiotherapy.